Salvage conformal radiotherapy for biochemical recurrent prostate cancer after radical prostatectomy

International Braz J Urol

Volumn 32, Issue 4, 2006, Pages 416-427

  Monti, Carlos R ^a,b   Nakamura, Ricardo A ^a   Ferrigno, Robson ^a   Rossi Jr , Aristides ^a   Kawakami, Neusa S ^a   Trevisan, Felipe A ^a  

^a Radium Oncology Institute   (Brazil)

^b NONE   (Brazil)

Author keywords

Prostate specific antigen; Prostatic neoplasms; Radiotherapy; Salvage therapy

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER CAPACITY; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DOSIMETRY; DYSURIA; FOLLOW UP; HEMATURIA; HUMAN; MALE; METASTASIS; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL RATE; SURVIVAL TIME; URINE INCONTINENCE; URINE RETENTION;

EID: 33748939790     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382006000400006     Document Type: Article

References (19)

1. Stephenson AJ, Shariat SF, Zelefsky MJ, Kattan MW, Butler EB, Teh BS, et al.: Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA. 2004; 291: 1325-32.
2. Cadeddu JA, Partin AW, DeWeese TL, Walsh PC: Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol. 1998; 159: 173-7; discussion 177-8.
3. Tsien C, Griffith KA, Sandler HM, McLaughlin P, Sanda MG, Montie J, et al.: Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy. Urology. 2003; 62: 93-8.
4. Catton C, Gospodarowicz M, Warde P, Panzarella T, Catton P, McLean M, et al.: Adjuvant and salvage radiation therapy after radical prostatectomy for adeno-carcinoma of the prostate. Radiother Oncol. 2001; 59: 51-60.
5. Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L, et al.: Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet. 2005; 366: 572-8.
6. Common Terminology Criteria for Adverse Effects version 3. (http:// ctep.cancer.gov/forms/CTCAEv3.pdf) accessed in 09/06/2005.
7. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys. 1997; 37: 1035-41.
8. Valicenti RK, Gomella LG, Perez CA: Radiation therapy after radical prostatectomy: a review of the issues and options. Semin Radiat Oncol. 2003; 13: 130-40.
9. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC: Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999; 281: 1591-7.
10. Forman JD, Wharam MD, Lee DJ, Zinreich ES, Order SE: Definitive radiotherapy following prostatectomy: results and complications. Int J Radiat Oncol Biol Phys. 1986; 12: 185-9.
11. Katz MS, Zelefsky MJ, Venkatraman ES, Fuks Z, Hummer A, Leibel SA: Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. J Clin Oncol. 2003; 21: 483-9.
12. Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, et al.: Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002; 53: 1097-105.
13. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, et al.: High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 2001; 166: 876-81. Erratum in: J Urol 2001; 166: 1839.
14. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, et al.: Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. J Urol. 2003; 170: 1833-7.
15. Maier J, Forman J, Tekyi-Mensah S, Bolton S, Patel R, Pontes JE: Salvage radiation for a rising PSA following radical prostatectomy. Urol Oncol. 2004; 22: 50-6.
16. Roach M 3rd, DeSilvio M, Lawton C, Uhl V, Machtay M, Seider MJ, et al.: Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol. 2003; 21: 1904-11.
17. Grossfeld GD, Stier DM, Flanders SC, Henning JM, Schonfeld W, Warolin K, et al.: Use of second treatment following definitive local therapy for prostate cancer: data from the caPSURE database. J Urol. 1998; 160: 1398-404.
18. Bahnson RR, Garnett JE, Grayhack JT: Adjuvant radiation therapy in stages C and D1 prostatic adenocarcinoma: preliminary results. Urology. 1986; 27: 403-6.
19. Gibbons RP, Cole BS, Richardson RG, Correa RJ Jr, Brannen GE, Mason JT, et al.: Adjuvant radiotherapy following radical prostatectomy: results and complications. J Urol. 1986; 135: 65-8.